Bone marrow transplantation is now a widely used treatment for several malignant and nonmalignant disorders' and offers a radical cure in affected children. However, the procedure is known to be associated with multiple organ failure, which is usually reversible. Transient intestinal failure following bone marrow transplantation is a common clinical problem because, unlike other forms of organ/tissue transplantation, bone marrow transplants often require the use of total body irradiation (TBI) in addition to immunosuppression. Cells with a rapid turnover, such as haemopoietic cells and immature enterocytes, are well recognised as being highly susceptible to the effects of radiation.
Early reactions following bone marrow transplants, such as mucositis, vomiting, diarrhoea, and anorexia, are well known in both adults and children.2 3 Delayed reactions, such as enteropathy4 and intrinsic or extrinsic intestinal obstruction following radiation injury to the gut have also been described.' In a recent study we showed that zinc deficiency occurred in 67% of patients following bone marrow transplant, and was associated with adverse clinical sequelae related to sepsis. It was more common in younger patients and significantly linked with diarrhoea. 6 Our understanding of the nature of gastrointestinal injury following bone marrow transplantation is at present fragmentary and mainly anecdotal. While mucosal damage,7 graftversus-host disease (GVHD),' pancreatic damage,9 10 and microbial injury" have all been reported after bone marrow transplants, the extent and the nature of any possible intestinal injury and its clinical and nutritional consequences have not been defined prospectively, either in adults or children. Management has tended to be entirely empirical. The aims of our study were therefore to define the natural history of the gastrointestinal injury associated with bone marrow transplantation, and to determine its effects on the clinical and biochemical indices of nutritional status and wellbeing. Methods
SUBJECTS
Forty seven consecutive patients (28 males, 19 females; mean age 8.4 years) who underwent bone marrow transplantation over a period of two years were enrolled into the study after obtaining informed consent. The characteristics of the patients, their primary diagnoses and the type of graft received are given in table 1 fore to 49 days A cause of diarrhoea was identified in 18 of -in was associ-the episodes as follows: gut GVHD, confirmed ioea compared by rectal biopsy, in eight; skin and/or liver 1 body irradia-GVHD in six; suspected CMV colitis in one; = 0.05), and of rotavirus infection in three. Thirteen diaruration was 9.6 rhoeal episodes were of uncertain cause. Howvely; p = 0.03. ever, six of them were associated with fever and i per se was not neutropenia and were probably infectious, t or prolonged although no pathogenic micro-organisms were found in the stools; in two, E coli and a faecal )ective of the streptococcus were isolated from blood culiatients before tures. Twenty three of the diarrhoeal episodes iical features of and 53 of the normal stools in the same transplantation patients, as well as 23 of the normal stools in 10 diarrhoea was of the children who did not develop diarrhoea, the use of were assessed for protein losing enteropathy in (76% of the and pancreatic insufficiency. In the other eight ral nutrition v diarrhoeal episodes, the tests failed, mainly .iteral nutrition because of difficulties in collecting the samples, 13)), and was of particularly in young ill patients (very watery (mean (SD) stools or contamination by urine). showed pancreatic insufficiency (mean stool chymotrypsin 46 ig/g wet stool) during diarrhoeal episodes, but in four patients pancreatic insufficiency was a late complication, with the main clinical symptoms of absent weight gain and occasionally offensive stools. Steatorrhoea (mean stool steatocrit 14%) was associated with only seven cases of pancreatic insufficiency (40%). In children who developed pancreatic insufficiency during diarrhoeal episodes, serial measurements of stool chymotrypsin were performed after diarrhoea had resolved and showed that pancreatic insufficiency persisted for up to one month after the end of diarrhoea. In all four cases who developed late pancreatic insufficiency, bone marrow transplantation was associated with the use of total body irradiation. Secretory diarrhoea was found in 10 of the 16 children (60%) whose diarrhoeal stools were collected and were loose enough to test: mean (SD) faecal sodium concentration and osmotic gap were 97 mmol/l (23.4) and 32 (12.8) respectively. The causes of diarrhoea in this group were: GVHD in five, suspected CMV infection in one, rotavirus infection in one, and uncertain in three.
Positive reducing substances were found in 14 of the 23 investigated diarrhoeal episodes (61 %). The causes of diarrhoea were GVHD in seven, rotavirus infection in two, possible CMV infection in one, and uncertain four. Six diarrhoeal episodes had a secretory component as well as positive stool reducing sugars.
Diarrhoea had a profound negative effect on the nutritional status of the affected patients, despite the provision of parenteral nutrition in the majority: mean (SD) changes in weight for height z scores in diarrhoeal versus nondiarrhoeal patients were -0.54 (0.6) v -0.12 (0.4) respectively; p = 0. 02 (fig 4) ; and mean (SDI) changes in mid-arm circumference z scores in diarrhoeal and non-diarrhoeal patients were -0.33 (0.4) and + 0.02 (0.3) respectively; p = 0.008.
Diarrhoea after bone marrow transplantation was associated with reduced wellbeing: median (range) of Lansky play performance score during diarrhoeal episodes and periods of normal stool in the same patients were 50 (10 to 80) compared with 70 (45 to 100) points,p < 0.0001 (fig5).
Intestinal permeability assessed by mannitol/ lactulose excretion ratios was found to be normal in 12 of the 14 investigated patients during the period of conditioning for bone marrow transplantation and in hospital following the transplant: median mannitol/lactulose corrected ratio 23.4 (normal >3'7).
Discussion
Our study showed that diarrhoea and hypoalbuminaemia were common following bone marrow transplants and were associated with adverse effects on nutritional status and wellbeing. Protein losing enteropathy and pancreatic insufficiency were also common after transplantation and were present in 91 % and 78%, respectively, of the diarrhoeal episodes investigated. Hypoalbuminaemia was worsened by diarrhoea and by protein losing enteropathy. Protein losing enteropathy complicating GVHD was more severe than when due to other causes. Intestinal permeability was normal in 86% of the investigated asymptomatic patients during conditioning therapies and after transplantation. ._ This study has several limitations. First is the absence of a complete dataset of indices of gastrointestinal function. Despite the best efforts of highly motivated nursing colleagues, it was not always possible, or indeed acceptable, to obtain urine and stool samples for non-clinical purposes from severely ill children. Second was our inability to identify stool pathogens in several of the unexplained diarrhoeal episodes. Third is the limited use of a colonoscopy and biopsy (due to neutropenia and the increased risk of infection)-investigations which might have allowed us to determine the cause of intestinal damage in other cases. It must be stated, however, that all studies of diarrhoea in immunocompromised patients contain a substantial proportion of subjects in whom no stool pathogen is identified.'8 Moreover, although the wider use of endoscopy in such patients has recently been advocated, its routine use in children with what is also self limiting diarrhoea is probably unjustified. '9 Hypoalbuminaemia has previously been attributed to several factors, such as increased catabolism, decreased protein synthesis, fluid redistribution, protein loss from the gut due to GVHD,"0 and protein loss from pulmonary capillaries.2' Although the aetiology of hypoalbuminaemia following bone marrow transplantation may be multifactorial, the significant negative correlation between the stool a,-antitrypsin and the fall in serum albumin suggested that protein loss from the gut was at least a major factor. Protein can be lost from the gut through an abnormal or inflamed mucosal surface. Radiation has been reported to have direct physical effects on tissues in animals,22 while GHVD has been shown to cause both a marked inflammation within the gut stroma and a degeneration and necrosis of the glandular epithelium and the crypt cells respectively.'3 Protein losing enteropathy has also been reported in association with rotavirus infection in this context,"4 while CMV infection was recently reported to simulate GVHD histologically. "5 This study showed that carbohydrate intolerance was common during diarrhoea. Radiation has been reported to cause varying degrees of villous atrophy4 associated with functional changes such as disaccharide and fat malabsorption.'6 Furthermore, an acceleration of orocaecal transit, associated with lactose and bile salt malabsorption, was recently reported in adults after abdominal irradiation. 27 In line with recent anecdotal reports,9 "' our study showed that pancreatic exocrine fimction may be impaired by bone marrow transplantation. Indeed, the incidence of transient pancreatic insufficiency following transplantation in our study was high. However, fat malabsorption was not common, probably because of anorexia and low oral fat intake during diarrhoea, or alternatively because lipase secretion may have not fallen to the very low level required for fat malabsorption to occur. The pathogenesis of pancreatic insufficiency following bone marrow transplantation has not been studied. GVHD has been implicated in the induction of pancreatic insufficiency in humans, in whom necropsy features of GVHD were reported in the pancreas.'8 Similar features have been found in experimental models of GVHD.'9 Total body irradiation and chemotherapy have been reported to induce pancreatitis following bone marrow transplantation.'0 Interestingly, one of our patients developed pancreatitis three months after bone marrow transplant and total body irradiation.
In contrast to previous reports in adults suggesting that the conditioning regimen leads to small bowel mucosal damage,'03' we found that intestinal permeability was normal in children without diarrhoea during the conditioning regimen and for up to six weeks after conditioning. Parrilli et al '3 reported a more than doubled intestinal permeability as early as the second day of treatment in all of nine patients undergoing cytotoxic chemotherapy. Fegan et al " reported an increased intestinal permeability peaking one to two weeks after conditioning in adults undergoing bone marrow transplantation. Intestinal permeability in that study was significantly increased in patients older than 30 years, was unrelated to the use of total body irradiation, and was correlated with the severity of gastrointestinal disturbance. We were unable to assess intestinal permeability during diarrhoeal episodes for three main reasons: unwillingness of some of the patients to drink the solution while feeling poorly; vomiting of the solution; or to the contamination of urine collection by diarrhoea especially in younger and female patients.
The gastrointestinal disturbance following bone marrow transplantation was shown to be associated with a marked adverse effect on nutritional status and on the wellbeing of affected patients, despite the provision of total parenteral nutrition to most of them. The nutritional management of the gastrointestinal sequelae of bone marrow transplantation is therefore challenging. The fact that 50% of diarrhoeal episodes developed after the start of parenteral nutrition poses the question of whether enteral feeding might have been more protective to the gut and more beneficial to the patients. Parenteral nutrition is associated with atrophic changes in the gut and reduced pancreatic function in animals." 3 It is also associated with a higher infection rate in critically ill patients than enteral nutrition. '4 Bacterial translocation to the circulation from the gut has been implicated as a contributory factor.'5 Enteral nutrition has been shown to preserve intestinal barrier function in animal models,36 and to improve immunity, reduce infection rate, and improve outcome in humans.'7 Recent studies have shown a beneficial effect of dietary supplements such as glutamine and fermentable fibre on gut mucosal turnover, thereby protecting intestinal barrier function from a variety of injurious agents. '8 39 We conclude that gastrointestinal injury following bone marrow transplantation is complex and has profound effects on nutritional status and wellbeing of the patients. Further prospective studies evaluating the preferred route of nutrient administration are required.
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